Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 6:23 pm Purchase |
2021-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Rock Springs Capital Management LP | 1,538,814 5.020% |
42,289 (+2.83%) |
Filing History |
| 2022-02-14 6:23 pm Purchase |
2021-12-31 | 13G | Immunocore Holdings plc IMCR |
Rock Springs Capital Management LP | 2,471,555 5.640% |
141,770 (+6.09%) |
Filing History |
| 2022-02-14 6:22 pm Purchase |
2021-12-31 | 13G | Compass Therapeutics, Inc. CMPX |
Rock Springs Capital Management LP | 5,328,088 5.440% |
4,071 (+0.08%) |
Filing History |
| 2022-02-14 6:22 pm Purchase |
2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Rock Springs Capital Management LP | 3,861,347 6.310% |
1,185,247 (+44.29%) |
Filing History |
| 2022-01-03 4:15 pm Purchase |
2021-12-22 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 823,654 11.480% |
513,493 (+165.56%) |
Filing History |
| 2021-12-30 4:40 pm Purchase |
2021-12-20 | 13G | Compass Therapeutics, Inc. CMPX |
Rock Springs Capital Management LP | 5,324,017 5.430% |
5,324,017 (New Position) |
Filing History |
| 2021-07-15 4:31 pm Sale |
2021-06-28 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 310,161 4.670% |
-331,994 (-51.70%) |
Filing History |
| 2021-07-08 4:25 pm Purchase |
2021-06-28 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 642,155 9.680% |
642,155 (New Position) |
Filing History |
| 2021-06-24 4:29 pm Purchase |
2021-06-14 | 13G | Chiasma, Inc. CHMA |
Rock Springs Capital Management LP | 3,243,600 5.600% |
3,243,600 (New Position) |
Filing History |
| 2021-05-17 4:17 pm Purchase |
2021-05-07 | 13G | F-star Therapeutics, Inc. FSTX |
Rock Springs Capital Management LP | 1,054,232 5.730% |
1,054,232 (New Position) |
Filing History |
| 2021-04-19 4:25 pm Purchase |
2021-04-09 | 13G | Immunocore Holdings plc IMCR |
Rock Springs Capital Management LP | 2,329,785 5.320% |
2,329,785 (New Position) |
Filing History |
| 2021-03-01 5:00 pm Purchase |
2021-02-18 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
Rock Springs Capital Management LP | 3,041,559 6.930% |
3,041,559 (New Position) |
Filing History |
| 2021-02-16 4:32 pm Purchase |
2020-12-31 | 13G | Ardelyx, Inc. ARDX |
Rock Springs Capital Management LP | 20,592,448 5.700% |
631,700 (+3.16%) |
Filing History |
| 2021-02-16 4:32 pm Purchase |
2020-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Rock Springs Capital Management LP | 1,496,525 5.080% |
251,525 (+20.20%) |
Filing History |
| 2021-02-16 4:32 pm Purchase |
2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Rock Springs Capital Management LP | 2,676,100 6.240% |
462,244 (+20.88%) |
Filing History |
| 2021-02-16 4:32 pm Sale |
2020-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rock Springs Capital Management LP | 1,314,374 4.480% |
-337,500 (-20.43%) |
Filing History |
| 2021-02-16 4:32 pm Sale |
2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 1,631,000 7.030% |
-77,673 (-4.55%) |
Filing History |
| 2021-02-16 4:32 pm Purchase |
2020-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Rock Springs Capital Management LP | 567,358 5.140% |
12,281 (+2.21%) |
Filing History |
| 2021-02-16 4:32 pm Sale |
2020-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Rock Springs Capital Management LP | 643,200 5.740% |
-422 (-0.07%) |
Filing History |
| 2020-11-16 4:59 pm Purchase |
2020-11-06 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rock Springs Capital Management LP | 1,651,874 5.630% |
526,874 (+46.83%) |
Filing History |